PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28461340-7	2017	Treatment with BAY 11-7082 or BBG 1 h after CAR injection attenuated pulmonary membrane thickening and polymorphonuclear leukocyte infiltration, reduced NF-kappaB translocation in the nucleus, and inhibited the assembly of the NRLP3/ASC/caspase-1 complex.	coomassie Brilliant Blue	30-33	caspase 1	Mus musculus	237-246	
28669743-7	2017	These results indicated that inhibition of P2X7R with BBG promoted neuronal survival, not through the activation of survival kinase pathways, but possibly by improved intracellular Ca2+ overload and decreased the levels of Caspase 1, IL-1beta and Bax proteins.	coomassie Brilliant Blue	54-57	caspase 1	Mus musculus	223-232	
29070142-4	2017	RESULTS: The allo-HSCT aGVHD mouse model was successfully established, the intraperitoneal injection of BBG alleviated the aGVHD clinical manifestations including roachback, ruffled fur, skin peeling and weight loss of recipient mice, decreased P2X7R and IL-1beta expression and reduced the mRNA levels of P2X7R, NLRP3, Caspase-1, IL-1beta and IL-18.	coomassie Brilliant Blue	104-107	caspase 1	Mus musculus	320-329	
26349656-9	2016	Apyrase, an adenosine triphosphate (ATP) scavenger, or Brilliant Blue G, a purinergic P2X7 receptor antagonist, inhibited the damage as well as caspase-1 activation and IL-1beta processing, despite there being sufficient amounts of pro-IL-1beta and NLRP3.	coomassie Brilliant Blue	55-71	caspase 1	Mus musculus	144-153	
24022661-8	2013	Blockade of P2X7 activation by BBG suppressed NLRP3/ASC/caspase 1 assembly and the subsequent release of interleukin-1beta (IL-1beta), resulting in a significant reduction in the severity of nephritis and circulating anti-dsDNA antibodies.	coomassie Brilliant Blue	31-34	caspase 1	Mus musculus	56-65